Mednews Week Keynote Conference - Dr. Scott T. Tagawa - Prostate Cancer

MedNews Week Keynote Conference - Dr. Scott T. Tagawa (Weill Cornell Medicine) - Prostate Cancer

MedNews Week Keynote - GU Oncology Update on Prostate Cancer - Dr. Scott T. Tagawa - Weill Cornell

Targeted Diagnostics & Therapeutics in Advanced PC Surveying PSMA Data

Scott Tagawa, MD, on the Prostate Cancer Treatment Pipeline

Dr. Tagawa on BRCA2 in Patients with Prostate Cancer Receiving PSMA-Targeted Radionuclide Therapy

Scott Tagawa, M.D. on PSMA PET-CT and its Utility in Prostate Cancer - Part 1

Dr. Tagawa on Targeting PSMA in Prostate Cancer

PSMA Imaging: VISION Trial with Dr. Scott Tagawa

Weill Cornell Urology - Grand Rounds: Dr. Scott T. Tagawa

Weill Cornell Urology

Scott Tagawa, MD, on PSMA Targeting in Prostate Cancer Treatment

Dr. Tagawa on CTC in Neuroendocrine-Positive Prostate Cancer

Dr. Tagawa on Remaining Questions With PSMA-Targeted Radionuclide Therapy in mCRPC

Scott Tagawa, MD, on the Impact of Racial Disparity and COVID-19 on Prostate Cancer Clinical Trials

Scott Tagawa, M.D., M.S.

Weill Cornell Genitourinary (GU) Cancer Program

Dr. Tagawa Discusses Agents Targeted Against PSMA

Targeted Oncology

Dr. Tagawa on Preliminary Data With 225Ac-J591 in mCRPC

Scott Tagawa, MD, on promising PSMA products in development for prostate cancer treatment

Blood in Urine: Could It Be Prostate Cancer? | Dr Teoh Boon Wei

Radiogland Therapy Optimization of Prostate Specific Membrane AntigenTargeted Radiation

Grand Rounds in Urology

Scott Tagawa, MD, defines the 177Lutethium Beta emitter and the 225Actinium Alpha emitter